Inve Learning Series
Reverse DCF: Read What the Price Already Expects
A reverse DCF reads the growth already baked into a stock's price, so you stop guessing value. See the implied growth on Titan and ask: is it believable?
Inve Content Team · 22 June 2026
When you buy a jacket, you check the price tag and ask whether the jacket is worth it. When most people buy a stock, they do the opposite — they decide the company is wonderful, then look at the price and assume it must be fair. They never turn the tag over and read what it is actually charging them for.
Here is the thing the tag is charging you for: future growth. A high price isn't a verdict that a business is good. It's a bill for growth that hasn't happened yet. And the most useful skill in valuation isn't guessing what a company is worth — it's reading what growth the current price has already assumed, and asking, in plain words, is that believable?
That backwards reading has a name. It's called a reverse DCF.
What a reverse DCF actually is
A normal DCF — discounted cash flow — works forwards. You guess how much cash a business will throw off every year for the next decade or two, you "discount" those future rupees back to what they're worth today (a rupee in 2036 is worth less than a rupee now, because you could have invested today's rupee in the meantime), and you add it all up to get a value. Then you compare that value to the price.
The trouble is the guessing. Change your growth assumption by two percent and the answer can swing by half. As Mauboussin and Rappaport put it in Expectations Investing, "rather than forecasting cash flows, investors should begin by estimating the expectations embedded in a company's stock price" (Expectations Investing, Mauboussin & Rappaport). They use a high-jump image: instead of betting how high a jumper can leap, first see how high the bar has already been set.
So a reverse DCF flips the order. You take the one number you actually know for certain — today's price — and you solve backwards for the only unknown that would make that price fair: the growth rate the market is assuming. You don't have to be right about the future. You only have to judge whether the market's assumption is reasonable. That is a far easier, far more honest question.
You can do the precise arithmetic in a spreadsheet. But you can do the thinking — which is what matters — on the back of an envelope. Let me show you with a real, richly-priced Indian business.
Turning the tag over on Titan
Take Titan Company, the Tata-group business behind Tanishq jewellery, Titan and Fastrack watches, and the Titan Eye+ eyewear chain. By any measure of the business itself, it has been excellent. Revenue grew from about ₹40,575 crore in FY23 to ₹87,584 crore in the trailing twelve months — that's roughly a 29% compound annual growth rate, sales up about 2.2 times in three years (Inve data, 2026). The store network tells the same story: by March 2025 its jewellery brands — Tanishq, Mia, Zoya and CaratLane — spanned 1,091 exclusive outlets, with the company crossing ₹50,000 crore in revenue and growing 22% for the full year (Titan Company FY25 results release, May 2025). This is a genuinely good business firing on most cylinders.
Now turn the tag over. Titan's market value is about ₹3,70,127 crore against trailing net profit of ₹5,074 crore — a price-to-earnings ratio (the price you pay for ₹1 of annual profit) of about 73 (Inve data, 2026). It trades at roughly 24 times its book value and 4 times its annual sales. For comparison, the broad Indian market sits closer to 20–25 times earnings. Titan isn't priced as a good business. It's priced as a great business that is going to stay great for a very long time.
So what does 73 times earnings actually demand? Here is the envelope. A mature, steady consumer business in a calm market might reasonably trade at, say, 25 times earnings one day. For Titan's profit to grow into that multiple from today's price — to make 73x look like 25x in hindsight — its earnings would need to roughly triple over the coming years while it keeps compounding. Profit growing 25% a year for a decade multiplies it more than nine-fold; even 20% a year multiplies it about six-fold (Inve data, 2026). And here's the catch worth noticing: over the same three years that sales grew 29% a year, profit compounded only about 16% (Inve data, 2026), because gold prices and a shifting product mix squeezed margins. The price isn't asking Titan to be good. It's asking Titan to open hundreds more jewellery stores, win share from the unorganised market, and fix the gap between sales growth and profit growth — and keep that engine roaring for the better part of a decade without a serious stumble.
That is the bar the high-jumper has to clear. The reverse DCF didn't tell you whether Titan will clear it. It told you exactly how high it's set — and that's the whole point.
"Price is what you pay. Value is what you get." — Warren Buffett
Test yourself
1/3. What is a reverse DCF trying to find?
2/3. A stock trades at 73 times earnings. What does that high multiple mainly represent?
3/3. After a reverse DCF shows a stock needs ~25% profit growth for a decade to justify its price, what's the right next question?
Why this beats forecasting
The reason this reframe is so powerful is that it changes who has to be right.
In a forward DCF, you have to predict the future — and you'll anchor on whatever growth number lets you justify a stock you already like. (Watch yourself do it: the assumption always drifts to fit the conclusion.) In a reverse DCF, the market has made the prediction, out loud, in the price. Your only job is the thing humans are genuinely better at than forecasting: judging whether someone else's bold claim is reasonable. You've sized up a friend's "I'll definitely lose 10 kilos by Diwali" a hundred times. Same skill.
It also dissolves the lazy debate that dominates stock chatter — "is this a buy?" A reverse DCF replaces it with a sharper one: what would have to be true? For Titan at 73x, what must a five-year owner believe? That Tanishq keeps adding stores at a brisk pace and pulling share from family jewellers, that profit growth finally catches up with sales growth rather than lagging it, that volatile gold prices and the studded-jewellery mix stop squeezing margins. Maybe all of that is true. But now you're arguing about the actual business, not a number on a screen. That's the conversation worth having — and it's the same logic behind a margin of safety: you want the bar set lower than what you believe the business can clear, not higher.
This is also where reading the company directly earns its keep. The expectations baked into the price are bets about specific things — store additions, same-store sales, margins — and management talks about exactly those on every earnings call. When you've read what management guided last quarter and whether they delivered, you're judging the high-jumper's actual training, not just admiring the height of the bar. (Tracking that quarter after quarter across a 10-stock portfolio is the tedious part nobody has time for — it's the job Inve's Promise Tracker exists to do.)
To be clear: none of this is a view on Titan's stock. It may grow into its price beautifully, or it may not — that's not the point. The point is the habit. None of this is a buy or sell call on Titan.
Where the back-of-envelope version can fool you
Munger's rule is to argue the other side before you trust your own. So here's where this rough method is weakest.
A crude reverse DCF can make a great business look impossibly expensive when it isn't. Titan's recent profit is held back by forces that may not last — a long stretch of rising gold prices and a shift in product mix have squeezed jewellery margins, and a fast-expanding retailer carries heavy upfront costs for stores that haven't matured yet, which depresses today's earnings relative to tomorrow's. A business with a long runway in a vast, still-largely-unorganised jewellery market deserves a multiple that looks rich against this year's number. The 73x isn't automatically irrational; the market may simply be paying for a runway, and a margin recovery, you haven't fully counted.
So the envelope is a thinking tool, not a verdict. It tells you the expectation the price embeds. Whether that expectation is too high, about right, or even too low is a judgement about the business — its moat, its runway, the honesty of its management — that no formula will hand you. Use the reverse DCF to find the question. Then go do the work to answer it.
See it on a live earnings call
Browse AI-analysed concall summaries — guidance tables, graded Q&A, and the quotes behind them — for 1,500+ listed Indian companies.
Browse concall summariesFrequently asked questions
Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.